Aviva


Fully in line and no change in our stance

16/11/23 -"Aviva gave a Q3 update that confirmed the positive turnaround for the company. Beside that no material news was shared. Despite facing challenges from two major storms (Babet and Ciarán) during the ..."

Pages
54
Language
English
Published on
16/11/23
You may also be interested by these reports :
04/12/23
Following the 9M23 trading update, our model has been adjusted to reflect the results, which were broadly in line with our projections for top-line ...

01/12/23
Swiss Re announced some new targets at today’s Investors´ Day. The Group is targeting IFRS net income of more than $3.6bn for 2024 compared with more ...

29/11/23
We have cut our Generali Target Price due to the weaker H2 which was impacted by higher NatCat losses than had been forecast in our previous model. ...

22/11/23
Helvetia has also released a profit warning for H2 23, having estimated the net claims burden from natural catastrophes and major loss events in Q3 ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO